Fed_Biz_Synopsis_Hamilton.docx

DOCX document 17 KB Posted

Attached to
Hamilton LabElite I. D Capper
Solicitation number
2017-Q-66939
Issued by

About this file

Notice of Intent to Sole Source

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

The Centers for Disease Control and Prevention (CDC), Nation Centers for Environmental Health, Division of Laboratory Sciences intends to award a sole source firm-fixed price equipment purchase contract to Hamilton Company 4970 Energy Way Reno, NV 89502. This contract will be for 120 days from time of award.

The statutory authority for this sole source acquisition is 10 U.S.C. 2304 (c) (1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement.

The Hamilton LabElite I.D Capper is needed for high throughput sample processing by the CDC Chemical Emergency Response Labs. Uncapping and capping of sample tubes are required for sample distribution and are in compliance with CLIA and ISO sample processing requirements. The Hamilton LabElite products are the only products that meet these specific requirements for multiple internally and externally threaded tube types. This capping device meets the laboratory needs interoperability throughout sample logistics to maintain emergency response preparedness in case of a national chemical exposure.

Hamilton Company is the only source to can provide the Hamilton LabElite products.

The NAICS code is 334516 Analytical Laboratory Instrument Manufacturing with a size standard of 1,000 employees.

No solicitation will be posted to FedBizOpps. We will only issue a solicitation to Hamilton Robotics. Hamilton Robotics is the only source available to provide this equipment that meets mission critical requirements. This notice of intent is not a request for proposal. A determination to compete this procurement based on response to this notice is solely within the discretion of the Contracting Officer.

Interested parties who believe they possess the capability to satisfy this requirement should submit a capability statement demonstrating their ability to meet this requirement. All responses must be sent in writing to Ms. Genesika Carter via email to fkn7@cdc.gov using solicitation number 2017-Q-66939 in the subject line, no later than 12:00pm Eastern Time, June 19, 2017.

Place of Contract Performance:

Centers for Disease Control and Prevention 4770 Buford Hwy Atlanta, GA 30341

File details come from the government source that posted it. Updated .